Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
Clinical trial NCT02358356 · COMPLETED
Trial details
- NCT number
- NCT02358356
- Sponsor
- Australasian Gastro-Intestinal Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2021-10-31
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.